Ketamine (Ketalar)

DRUG4 trials

Sponsors

University of Helsinki, Icahn School of Medicine at Mount Sinai, University of Utah, Stanford University

Conditions

Chronic PainKetaminePainPostpartum DepressionSevere DepressionSuicidal Ideation

Phase 1

Ketamine Pharmacokinetics and Pharmacodynamics for Postpartum Depression and Pain After Cesarean Delivery

SuspendedNCT06767566

University of UtahPain, Postpartum Depression

Start: 2025-03-28End: 2028-03-01Target: 50Updated: 2026-06-29

Phase 2

Psilocybin and Depression

University of HelsinkiSevere Depression

Start: 2018-09-30End: 2021-09-30Target: 60Updated: 2017-12-21

Intramuscular Ketamine for Suicidal Ideation

WithdrawnNCT05105061

Icahn School of Medicine at Mount SinaiSuicidal Ideation

Start: 2022-02-28End: 2022-03-24Updated: 2022-04-05

Unknown Phase

Outcomes Registry After Ketamine Infusions for Chronic Pain: A Longitudinal Evaluation

Not yet recruitingNCT07648771

Stanford UniversityChronic Pain, Ketamine

Start: 2026-10-01End: 2034-12-01Target: 800Updated: 2026-09-15